Categories Sites GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots – Bloomberg Post author By Mike Nova Post date July 3, 2024 GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots Bloomberg The post GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots – Bloomberg first appeared on The CoronaVirus Alerts – The News And Times. ← Lawfare Daily: Anupam Chander, Kyle Langvhardt, and Alan Rozenshtein on the Supreme Court’s Decision in Moody v. NetChoice → CureVac gains $430M GSK vaccine contract, loses 30% of staff – Fierce Biotech